KEMPHARM, INC (KMPH) Director: Plooster Matthew R Acquired 3,572 Common Stock (Non-Derivative security at $3.900) on Feb 10, 2016. Direct holding 8,117 shares/units after transaction. Holdings increased 78.59%. Insider filing date: Feb 12, 2016 Record updated: 00:00:34.
Pennystocksinsiders.com focuses on tracking and monitoring top market movers and insider trading activities in the US stocks market. "Insider Trading" means trading
activities created by company directors, senior officers, individual substantial shareholders, and institutional
shareholders. Pennystocksinsiders.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or
timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively,
the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services
contained on the website (the "Service"), nor the quality of any products, information or other materials displayed,
purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection
with the Service (the "Products"). Pennystocksinsiders.com collects insider trading information from different public sources
such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that
any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the
Pennystocksinsiders.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision.
Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind
of investment decision in relation to them without first obtaining independent investment advice from a person authorized
to give it.